Blog

Aleix Prat: Representing Both the Clínic Barcelona Comprehensive Cancer Center and Reveal Genomics at ASCO25

Aleix Prat/clinicbarcelona.org

May 29, 2025, 12:53

Aleix Prat: Representing Both the Clínic Barcelona Comprehensive Cancer Center and Reveal Genomics at ASCO25

Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared a post on LinkedIn:

“Heading to ASCO25 with great pride — representing both the Clínic Barcelona Comprehensive Cancer Center and REVEAL GENOMICS in what promises to be a landmark year.

The Clínic Barcelona Comprehensive Cancer Center will present many scientific contributions across multiple tumor types, including breast, lung, bladder, melanoma, glioblastoma, prostate, liver, and digestive cancers. These span oral presentations, rapid abstracts, posters, and educational sessions — highlighting our strong commitment to biomarkers, immunotherapy, targeted therapies, and treatment optimization strategies.

We’ll also be sharing new data from HER2DX, featured in an oral presentation of the CompassHER2-pCR trial (led by ECOG-ACRIN and NCI), where the test identified patients most likely to achieve pCR to a non-anthracycline regimen. Altogether, more than 800 patients across four independent studies reinforce HER2DX’s clinical value in early-stage and metastatic HER2+ breast cancer.

Looking forward to impactful discussions and collaborations in Chicago.”

Aleix Prat previewed extensive participation by the Clínic Barcelona Comprehensive Cancer Center and REVEAL GENOMICS at ASCO 2025, including new HER2DX data from the CompassHER2-pCR trial highlighting its clinical utility in HER2+ breast cancer.

More posts featuring Aleix Prat.

Aleix Prat ASCO25 biomarkers Bladder breast Breast Cancer cancer Clinic Barcelona Comprehensive Cancer Center CompassHER2-pCR trial ECOG-ACRIN fight against cancer glioblastoma Global fight against cancer HER2 HER2DX Hospital Clinic of Barcelona immunotherapy liver lung Melanoma NCI OncoDaily Oncology prostate Reveal Genomics targeted therapies

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action